Research and Development

Showing 15 posts of 9573 posts found.

fda_building_web

FDA approves first treatment for the ‘silent killer’

August 30, 2017 Research and Development, Sales and Marketing Chagas disease, FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced that it has granted an accelerated approval for the use of benznidazole in children between the ages …
brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017 Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …
ecstasy_monogram

FDA fast-tracks recreational drug MDMA for treatment of PTSD

August 30, 2017 Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals

In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …
astrazeneca_logo_building

AstraZeneca unloads another drug for $400m

August 29, 2017 Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical

AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …

Novartis names new Chief Digital Officer

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
adults-1853851_960_720

Thyroid disorders: An illness underestimated

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …
800px-cancer_cells_1

New research reports first-ever response of central nervous tumour to CAR T therapy

August 29, 2017 Manufacturing and Production, Research and Development CAR T, CAR-T, Cancer, life sciences, lymphoma, medicine, pharma, pharmaceuticals

Researchers at a General Hospital in Massachusetts has reported what they claim is the first response of a nervous system …

Novartis’ drug prevents heart attacks and cancer but faces major challenges

August 29, 2017 Manufacturing and Production, Research and Development Novartis, biotech, drugs, pharma, pharmaceutical

It would be expected that when a company releases data to show that its drug, previously only used in a …
merckincweb

MSD scores trial success in reducing cardiovascular risk

August 29, 2017 Manufacturing and Production, Research and Development MSD, heart attack, heart disease, life sciences, pharma, pharmaceutical

New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …
astrazeneca-sign

AstraZeneca invests “tens of millions” into Cheshire, UK manufacturing site

August 29, 2017 Manufacturing and Production, Research and Development AZ, AstraZeneca, Cheshire, Chesire, UK, life sciences, pharma, pharmaceuticals

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …
glass-1206584_960_720

Lithium levels in water supply could prevent dementia

August 25, 2017 Research and Development biotech, drugs, lithium, pharma, pharmaceutical

Lithium has long been used in the treatment of people living with bipolar disorder and animal studies have found potential …
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

August 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten

As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …
astrazeneca_building_white

Extended use of AstraZeneca’s Brilinta reduces cardiovascular death risk

August 24, 2017 Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, life sciences, pharma, pharmaceutical

New data for AstraZeneca’s blood thinner Brilinta (ticagrelor) has shown that extended use of the drug can cut the risk …

Novartis names new Chief Digital Officer

August 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment, digital pharma, life sciences, pharma, pharmaceuticals

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
The Gateway to Local Adoption Series

Latest content